Watchlist Price Alert

Altamira Therapeutics Ltd... (CYTO)

NASDAQ: CYTO · Real-Time Price · USD

0.30

0.00 (0.00%)

At close: Jan 16, 2025, 9:00 PM

Altamira Therapeutics Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	617.41K	15.39K	984.19K	11.26M	1.38M	5.39M	14.97M	32.44M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	2.5M	194.26K	199.1K	20K	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	-4.53M	-15.08M	-9.16M	20K	242.87K	76.71K	114.78K
Receivables	74.82K	6.53K	21.75K	n/a	n/a	n/a	n/a	216.63K
Inventory	n/a	11.64K	839.22K	-358.17M	-988.49M	-80.04K	-79.84K	n/a
Other Current Assets	247.09K	270.18K	671.34K	n/a	219.62K	n/a	n/a	n/a
Total Current Assets	1.22M	1.77M	3.76M	11.62M	2.37M	6.06M	15.87M	33.69M
Property-Plant & Equipment	80.11K	445.83K	564.72K	46.64K	66.67K	33.9K	252.9K	369.29K
Goodwill & Intangibles	3.89M	3.89M	14.31M	9.12M	6.77M	3.54M	1.63M	1.48M
Total Long-Term Assets	6.47M	4.53M	15.08M	9.18M	6.85M	3.81M	1.96M	1.97M
Total Assets	7.69M	6.3M	18.84M	20.8M	9.23M	9.88M	17.83M	35.66M
Account Payables	413.11K	4.77M	3.54M	722.27K	906.5K	1.81M	1.03M	1.73M
Deferred Revenue	n/a	n/a	n/a	1.43M	n/a	-25.89K	-168.26K	n/a
Short-Term Debt	n/a	5.87M	n/a	523.92K	n/a	1.44M	4.54M	2.21M
Other Current Liabilities	190.61K	362.5K	196.92K	412.26K	47.92K	146.95K	217.65K	138.96K
Total Current Liabilities	888.91K	12.88M	4.86M	3.03M	2.28M	4.56M	10.43M	8.96M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	5.58M	10.15M
Other Long-Term Liabilities	346.63K	1.39M	812.04K	873.69K	764.8K	1.32M	3.98M	2.41M
Total Long-Term Liabilities	346.63K	1.74M	1.27M	999.56K	911.95K	1.66M	9.56M	12.56M
Total Liabilities	1.24M	14.62M	6.13M	4.03M	3.19M	6.23M	19.99M	21.52M
Total Debt	99.66K	6.33M	575.74K	523.92K	n/a	1.44M	10.13M	12.36M
Common Stock	2.65K	236.01K	149.64K	114.17K	1.65M	710.34K	19.35M	13.73M
Retained Earnings	-18.05M	-201.43M	-176.02M	-160.64M	-152.78M	-146.3M	-136.13M	-112.34M
Comprehensive Income	177.58K	258.04K	62.07K	61.3K	-27.57K	-44.01K	-33.05K	-83.54K
Shareholders Equity	6.46M	-8.31M	12.7M	16.77M	6.04M	3.65M	-2.16M	14.14M
Total Investments	2.5M	194.26K	199.1K	20K	n/a	n/a	n/a	n/a